centered image

That COVID-19 Vaccine Russia Approved? It's Only Cleared For Use In A Small Group Of People.

Discussion in 'General Discussion' started by In Love With Medicine, Aug 14, 2020.

  1. In Love With Medicine

    In Love With Medicine Golden Member

    Joined:
    Jan 18, 2020
    Messages:
    4,085
    Likes Received:
    3
    Trophy Points:
    7,180
    Gender:
    Male

    [​IMG]

    This week, Russian president Vladimir Putin announced that the country had approved a coronavirus vaccine, seemingly for widespread use. But the vaccine has actually been approved only for use in "a small number of citizens from vulnerable groups," according to Science Magazine.

    Russia named the new vaccine "Sputnik V," in reference to the world's first artificial satellite, launched during the space race, Reuters reported.

    "We must be grateful to those who made that first step very important for our country and the entire world," Putin said in a cabinet meeting Tuesday morning (Aug. 11) in reference to the vaccine developers, according to The Associated Press.

    Although Putin announced that the vaccine had been approved, presumably for widespread use, the registration certificate issued by Russia's Ministry of Health actually covers only a small group including health care workers, according to Science Magazine. The certificate also states that the vaccine cannot be approved for widespread use until Jan. 1, 2021, although statements by various Russian health officials seem to contradict that clause.

    "People outside of clinical trials will have access to the vaccine in August, and some, already on the massive scale, in October," Kirill Dmitriev, chief executive of the Russian Direct Investment Fund (RDIF), told reporters, according to the original Associated Press report posted Aug. 11. (RDIF funded the development of the vaccine.) Russian minister of health Mikhail Murashko said that the country will soon begin a mass campaign to distribute the vaccine, and that medical workers and teachers will be prioritized to receive it first, according to The New York Times.

    A phase 3 clinical trial of the vaccine, which will assess safety and efficacy more thoroughly, is scheduled to begin this week, Dmitriev told reporters, according to The Associated Press.

    Source
     

    Add Reply

Share This Page

<